Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies [clinicaltrials:NCT00024648]
Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies [clinicaltrials:NCT00024648]
Bio2RDF identifier
NCT00024648
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00024648
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
LErafAON is a liposome ...... equirements will be assessed.
brief title [clinicaltrials_vocabulary:brief-title]
Study to Determine Maximum Tol ...... nts With Advanced Malignancies
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2004-12-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... miting toxicity (DLT) occurs.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2001-09-24T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
advanced malignancy
antisense oligodeoxynucleotide (AON)
liposomes containing AON to c-raf messenger RNA
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-04-12T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00024648
official title [clinicaltrials_vocabulary:official-title]
Phase I Study to Determine the ...... nts With Advanced Malignancies
org study id [clinicaltrials_vocabulary:org-study-id]
LErafAON-001
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2001-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2011-04-01T00:00:00Z
identifier
clinicaltrials:NCT00024648
title
Study to Determine Maximum Tol ...... nts With Advanced Malignancies
@en
type
label
Study to Determine Maximum Tol ...... s [clinicaltrials:NCT00024648]
@en